Skip to main content
MOA Life Plus Co. Ltd. logo

MOA Life Plus Co. Ltd. — Investor Relations & Filings

Ticker · 142760 ISIN · KR7142760008 KO Manufacturing
Open in API
Filings indexed 361 across all filing types
Latest filing 2024-03-21 Major Shareholding Noti…
Country KR South Korea
Listing KO 142760

About MOA Life Plus Co. Ltd.

http://moalifeplus.com/

MOA Life Plus Co. Ltd. is a biopharmaceutical company that researches and develops innovative medicines and consumer healthcare products. The company's pharmaceutical division focuses on a pipeline of biopharmaceuticals, including immunotherapies, cancer treatments, and vaccines for infectious diseases. A core platform technology utilizes Gamma-Polyglutamic Acid (γ-PGA), a natural amino acid polymer derived from fermented foods, to enhance immune responses and serve as a vaccine adjuvant. The consumer business division provides tailored healthcare solutions for immunity enhancement, skin rejuvenation, and pet care. It also manufactures and supplies γ-PGA-based raw materials for the cosmetics industry.

Recent filings

Filing Released Lang Actions
최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding a change in the company's largest shareholder (최대주주변경). It details the previous and new major shareholders, the reason for the change (stock transfer agreement), and provides financial and background information on the new major shareholder. This type of disclosure is a standard regulatory announcement for material corporate events.
2024-03-21 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and the purpose of holding (management influence) by a major shareholder (Park Young Chul) of the company 'BL Co., Ltd.' (비엘). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-03-20 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares by '모아데이타' in '비엘', crossing the 5% threshold (6.95%). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system titled '감사보고서 제출' (Submission of Audit Report). It provides a summary of financial data, audit opinions, and key financial metrics (assets, liabilities, profit/loss) for the current and previous fiscal years. While it contains financial data, it is a standard regulatory disclosure form used to announce the receipt and submission of the audit report to the exchange, rather than the full, multi-page audited financial statement document itself. Therefore, it is classified as a regulatory filing. FY 2023
2024-03-20 Korean
사업보고서 (2023.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Consolidated Audit Report' (연결감사보고서) for the company 'BL Co., Ltd.' (주식회사 비엘). It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. This document represents the full annual financial reporting package for the fiscal year ending December 31, 2023, which aligns with the definition of an Annual Report (10-K) in the provided schema. FY 2023
2024-03-20 Korean
주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a decision for a paid-in capital increase (유상증자결정) by the company (주)비엘. It details the issuance of new shares, the purpose of the capital raise, the third-party allocation details, and the board's resolution. This falls under the category of capital and financing updates.
2024-03-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.